Literature DB >> 22860160

Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.

Yu Lu1, Michel Prudent, Bruno Fauvet, Hilal A Lashuel, Hubert H Girault.   

Abstract

α-Synuclein (α-syn) is a 140-amino acid protein that plays a central role in the pathogenesis of Parkinson's disease (PD) and other synucleinopathies. However, the molecular determinants that are responsible for triggering and/or propagating α-syn aggregation and toxicity remain poorly understood. Several studies have suggested that there are direct interactions between different metals and α-syn, but the role of metal ions and α-syn in the pathogenesis of PD is not firmly established. Interestingly, the majority of disease-associated post-translational modifications (PTMs) (e.g., truncation, phosphorylation, and nitration) of α-syn occur at residues within the C-terminal region (Y125, S129, Y133, and Y136) and in very close proximity to the putative metal binding sites. Therefore, we hypothesized that phosphorylation within this domain could influence the α-syn-metal interactions. In this paper, we sought to map the interactions between the di- and trivalent cations, Cu(II), Pb(II), Fe(II), and Fe(III), and the C-terminal region of α-syn encompassing residues 107-140 and to determine how phosphorylation at S129 or Y125 alters the specificity and binding affinity of metals using electrospray ionization-mass spectrometry (ESI-MS) and fluorescence spectroscopy. We demonstrate that D115-M116 and P128-S129 act as additional Cu(II) binding sites and show for the first time that the residues P128-S129 and D119 are also involved in Pb(II) and Fe(II) coordination, although D119 is not essential for binding to Fe(II) and Pb(II). Furthermore, we demonstrate that phosphorylation at either Y125 or S129 increases the binding affinity of Cu(II), Pb(II), and Fe(II), but not Fe(III). Additionally, we also show that phosphorylations at these residues lead to a shift in the binding sites of metal ions from the N-terminus to the C-teminus. Together, our findings provide critical insight into and expand our understanding of the molecular and structural bases underlying the interactions between α-syn and metal ions, including the identification of novel metal binding sites, and highlight the potential importance of cross-talk between post-translational modifications and metal ion binding in modulating α-syn functional and aggregation properties that are regulated by its C-terminal domain.

Entities:  

Keywords:  C-terminal; binding; mass spectrometry; metal ion; phosphorylation; α-Synuclein

Mesh:

Substances:

Year:  2011        PMID: 22860160      PMCID: PMC3369716          DOI: 10.1021/cn200074d

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  50 in total

Review 1.  The ABC's (and XYZ's) of peptide sequencing.

Authors:  Hanno Steen; Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

Review 2.  Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.

Authors:  Brian J Tabner; Stuart Turnbull; Omar M A El-Agnaf; David Allsop
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

3.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

4.  Copper(II)-induced self-oligomerization of alpha-synuclein.

Authors:  S R Paik; H J Shin; J H Lee; C S Chang; J Kim
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Proposal for a common nomenclature for sequence ions in mass spectra of peptides.

Authors:  P Roepstorff; J Fohlman
Journal:  Biomed Mass Spectrom       Date:  1984-11

6.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

7.  Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.

Authors:  S R Paik; H J Shin; J H Lee
Journal:  Arch Biochem Biophys       Date:  2000-06-15       Impact factor: 4.013

8.  Protein nitration is mediated by heme and free metals through Fenton-type chemistry: an alternative to the NO/O2- reaction.

Authors:  Douglas D Thomas; Michael Graham Espey; Michael P Vitek; Katrina M Miranda; David A Wink
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-11       Impact factor: 11.205

9.  NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.

Authors:  Claudio O Fernández; Wolfgang Hoyer; Markus Zweckstetter; Elizabeth A Jares-Erijman; Vinod Subramaniam; Christian Griesinger; Thomas M Jovin
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

10.  Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein.

Authors:  Ghiam Yamin; Charles B Glaser; Vladimir N Uversky; Anthony L Fink
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

View more
  39 in total

Review 1.  Dynamic structural flexibility of α-synuclein.

Authors:  Danielle E Mor; Scott E Ugras; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Neurobiol Dis       Date:  2015-12-31       Impact factor: 5.996

2.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

Review 3.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

Review 4.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

Review 5.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 6.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

7.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.

Authors:  Shounak Baksi; Ajai K Tripathi; Neena Singh
Journal:  Free Radic Biol Med       Date:  2016-06-23       Impact factor: 7.376

Review 8.  Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.

Authors:  Adrien W Schmid; Bruno Fauvet; Marc Moniatte; Hilal A Lashuel
Journal:  Mol Cell Proteomics       Date:  2013-08-21       Impact factor: 5.911

9.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

10.  Conversion of natively unstructured α-synuclein to its α-helical conformation significantly attenuates production of reactive oxygen species.

Authors:  Binbin Zhou; Yuanqiang Hao; Chengshan Wang; Ding Li; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2012-09-08       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.